TLDR Finasteride shows promise for preventing prostate cancer, but more research is needed.
The document discussed the potential of finasteride as a chemoprevention agent for prostate cancer, which had a high prevalence and significant morbidity and mortality. Finasteride met most criteria for chemoprevention, but further research was needed to clarify issues such as the increase in Gleason score, health savings, side effects on sexuality, impact on patient survival, and identifying the ideal target population before it could be recommended for practical use.
11 citations
,
February 2004 in “Clinical and Experimental Ophthalmology” Taking Propecia might lead to the development of cataracts.
1 citations
,
November 2014 The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.
2 citations
,
December 2006 in “Lancet Oncology” Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.
March 2013 in “Reactions Weekly” A man's fertility improved after he stopped taking finasteride but worsened again when he restarted the medication.
January 2012 in “Elsevier eBooks” New treatments for skin and hair repair show promise, but further improvements are needed.